Perioperative pharmacokinetics of factor VII concentrate during liver surgery in a patient with congenital factor VII deficiency: An individual mathematical model

Blood Coagulation and Fibrinolysis

Volumn 13, Issue 5, 2002, Pages 457-460

  Charpiat, B ^a   Laporte, Silvy ^a   Mismetti, P ^a   Debize, G ^a   Ducerf, C ^a  

^a SERVICE DE NEUROLOGIE   (France)

Author keywords

Factor VII deficiency; Liver surgery; NONMEM; Pharmacokinetics

Indexed keywords

BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR CONCENTRATE;

AGED; ARTICLE; BLEEDING; BLOOD CLOTTING FACTOR 7 DEFICIENCY; CASE REPORT; DRUG CLEARANCE; DRUG DISTRIBUTION; HEPATIC VEIN; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER SURGERY; MALE; MATHEMATICAL MODEL; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SUBSTITUTION THERAPY; THROMBOSIS; VEIN INJURY;

AGED; BLOOD LOSS, SURGICAL; CARCINOMA, HEPATOCELLULAR; FACTOR VII; FACTOR VII DEFICIENCY; HEPATECTOMY; HEPATIC VEINS; HEPATITIS C; HUMANS; INTRAOPERATIVE COMPLICATIONS; LIVER NEOPLASMS; MALE; MEDICAL ERRORS; MODELS, BIOLOGICAL;

EID: 0036631062     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200207000-00011     Document Type: Article

References (10)

1. Prophylaxis and therapy with factor VII concentrate (human) immuno, vapor heated in patients with congenital factor VII deficiency: A summary of case reports
2. Hepatocellular carcinoma in cirrhotic and noncirrhotic livers. A clinico-histopathologic study of 804 North American patients
3. Pharmacokinetics evaluation of recombinant activated factor VII in patients with inherited factor VII deficiency
4. Population pharmacokinetics of recombinant factor VIIa in volunteers anticoagulated with acenocoumarol
5. Evaluation of factor VIII pharmacokinetics in hemophilia-A subjects undergoing surgery and description of a nomogram for dosing calculations
6. Continuous infusion therapy in haemophilia
7. Use of recombinant activated VII in the treatment of congenital factor VII deficiencies
8. Efficacy and safety of recombinant factor VIIa in the prophylaxis of bleeding in various surgical procedures in hemophilic patients with factor VIII and factor IX inhibitors
9. Successful use of recombinant VIIa (Novoseven) and endometrial ablation in a patient with intractable menorrhagia secondary to FVII deficiency